Dr Borrós and Dr Fornaguera, leaders of the CoviNanoVax project
“We have our mRNA encapsulated, which appears from the outset that it will be immunogenic, stable and non-toxic, with stable nanoparticles at 4ºC, and obtained through an easily scalable process.“
Salvador Borrós Gómez, PhD
Director of IQS - Head of GEMAT Group - Professor
Cristina Fornaguera Puigvert, PhD
School of Engineering
Its activities focus on three main areas: the development of new functional materials, surface engineering and biomaterials.